FOR THE ATTENTION OF CONTRACTORS PROVIDING LIVING WELL SERVICE

Dear Colleague

Please find for your attention, correspondence from Kathryn Turner, Pharmacy Lead, HSCB and Stephen Wilson, Assistant Director of Communications and Knowledge Management, PHA.

Summary

  • Living Well Campaign ‘Vaccinations’ launched in December 2020 – if you have not received your resource pack please email reception.pha@hscni.net
  • Phase 2 resources of the ‘Vaccinations’ campaign, relating specifically to the COVID vaccination program, are currently being distributed – if not received by 13th January 2021 please email reception.pha@hscni.net

Action

As per the service specification, you must display the posters in at least one window unit of the pharmacy.

Reminder

  • As per previous correspondence your pharmacy is required to complete a short online evaluation survey for the previous LW campaign ‘Looking after your health and wellbeing during COVID-19’.
  • If you are yet to submit your pharmacy’s survey response, please complete here by Monday 18th January 2021.

Yours sincerely

SENT ON BEHALF OF GERARD GREENE | Chief Executive

Dear Colleague

Please find correspondence from the BSO here which outlines the timetable for prescription submissions to the BSO until April 2021.

Please note: To support contractors who have opted to bring their second December prescription submission directly to BSO, the BSO reception will remain open until 9pm on Tuesday 12th January 2021. It is important that any prescriptions being brought directly to BSO are handed to BSO personnel in the BSO reception and signed in accordingly.

Yours sincerely

SENT ON BEHALF OF GERARD GREENE | Chief Executive

Dear Colleague

The Department of Health has written to contractors detailing amendments that have been made to the Human Medicines Regulations 2012 (see here).

The Statutory Instrument (SI) titled The Human Medicines (Coronavirus) (Further Amendments) Regulations 2020 was laid before Parliament on the 18th December 2020 and a can be accessed at: www.legislation.gov.uk/id/uksi/2020/1594

Among other amendments, the SI provides that Patient Group Directions (PGDs) allowing a retail pharmacy business to administer COVID-19 or influenza vaccines may be used at a location other than a registered pharmacy, thus making it lawful for administration of such vaccines away from the registered pharmacy premises.

ACTION

Contractors are advised to: Note the amendments

CPNI colleagues will keep you informed of any further amendments to medicines legislation which impact on the community pharmacy sector.

Yours sincerely

Mike

SENT ON BEHALF OF PROF MIKE MAWHINNEY | Head of Regulatory Affairs

Provision of the COVID Vaccine for Pharmacy Staff 

Dear Colleague

Please see letter from Cathy Harrison, Chief Pharmaceutical Officer, DoH (NI) that provides confirmation and further information on the provision of the COVID Vaccine that will be made available to pharmacy staff members.

The letter also touches on the on-going development of plans for the inclusion of Community Pharmacy in the COVID Vaccination programme to the wider population in Northern Ireland.

Further information on both of these aspects will follow in due course this but I hope this initial letter provides reassurance to you and your pharmacy teams.

I trust this is helpful.

Yours sincerely

SENT ON BEHALF OF GERARD GREENE |  Chief Executive

Provision of the COVID Vaccine for Pharmacy Staff 

Dear Colleague
Please see letter from Cathy Harrison, Chief Pharmaceutical Officer, DoH (NI) that provides confirmation and further information on the provision of the COVID Vaccine that will be made available to pharmacy staff members.

The letter also touches on the on-going development of plans for the inclusion of Community Pharmacy in the COVID Vaccination programme to the wider population in Northern Ireland.

Further information on both of these aspects will follow in due course this but I hope this initial letter provides reassurance to you and your pharmacy teams.

I trust this is helpful.

Yours sincerely

SENT ON BEHALF OF GERARD GREENE |  Chief Executive

Seasonal Influenza Vaccination Programme 2020/21
Extension to 50-64 Year Olds

Dear Colleague

Please find letter here from Dr Michael McBride, Chief Medical Officer Prof Charlotte McArdle, Chief Nursing Officer and Mrs Cathy Harrison, Chief Pharmaceutical Officer.

SUMMARY

  • The Department of Health has extended the Seasonal influenza vaccination programme for 2020/2021 to include patients who will be aged 50-64 years old by 31st March 2021.
  • CPFV service is to be extended to include those aged from 50 to 64 years old, who are registered with a GP practice in NI, as well as the previous target group of Health and Social Care Workers.
  • The 50 to 64 year old cohort are able to receive the Cell-grown Quadrivalent Inactivated Vaccine (QIVc) or Egg- grown Quadrivalent Inactivated Vaccine (QIVe) through contracted community pharmacies or GP practices, free of charge.

CONTRACTOR ACTION

. The anticipated start date for the extended program is Monday 11th January 2021.
. An updated contract will be distributed by HSCB, with the additional patient cohort, and will need to be signed and retained within the pharmacy for record purposes.
. The service specification, PGD, privacy notice and all supporting documents are currently being amended to reflect the additional cohort of patients and will be added to www.pha.site/CPFV by the end of this week.
. Updated Standard Operating Procedures will need to be amended and signed.
. The CPFV e-record form is currently being updated to allow pharmacists to select the appropriate patient cohort.
. Additional vaccine stock is available through Movianto and can be ordered in the normal way.
. A communication plan is being developed between HSCB, PHA and CPNI and will be available shortly.
. Posters to advertise the service will be distributed to contractors from HSCB in due course.

HSCB correspondence will be issued shortly on operational issues, but if you have any queries in the interim, please contact either: Chris Blayney chris.blayney@hscni.net or Greg Miller greg.miller@hscni.net or the CPNI office.

Yours sincerely

Vanessa

SENT ON BEHALF OF DR. VANESSA CHAMBERS | Head of Policy & Development